CMV neurological disease
Also known as: Cytomegalovirus neurological disease / Cytomegalovirus encephalitis / Encephalitis cytomegalovirus / Other cytomegaloviral diseases / Cytomegalovirus encephalitis (disorder) / Encephalitis CMV / Cytomegaloviral encephalitis
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB01004 | Ganciclovir | A DNA polymerase inhibitor used to treat cytomegalovirus and herpetic keratitis of the eye. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB01004 | Ganciclovir | DNA polymerase catalytic subunit | target |
| DB01004 | Ganciclovir | Solute carrier family 22 member 1 | transporter |
| DB01004 | Ganciclovir | Solute carrier family 22 member 6 | transporter |
| DB01004 | Ganciclovir | Solute carrier family 22 member 8 | transporter |
| DB01004 | Ganciclovir | Solute carrier family 22 member 7 | transporter |
| DB01004 | Ganciclovir | DNA | target |
| DB01004 | Ganciclovir | Multidrug and toxin extrusion protein 1 | transporter |
| DB01004 | Ganciclovir | Multidrug and toxin extrusion protein 2 | transporter |
| DB01004 | Ganciclovir | Thymidine kinase | target |
| Drug | Drug Name | Phase | Status | Count |
|---|